Roche’s MS drug fenebrutinib delivers striking Phase III results by cutting relapse rates by 58%

The company announced that its Phase III FENhance 1 and 2 studies both met their primary endpoints

ENSPRYNG cuts MOGAD relapse risk by 68% in landmark Phase III trial: Roche

The Phase III METEOROID study met its primary endpoint, with ENSPRYNG cutting the risk of a first relapse by 68% compared to placebo in adults and adolescents

Samsung Bioepis unveils promising preclinical data for novel ADC SBE303 at AACR 2026

SBE303 targets Nectin-4, an adhesion protein overexpressed in multiple tumor types, including urothelial, lung, and breast cancers

Aster CMI Hospital launches Karnataka’s first pediatric liver ICU ‘PEARL’

The unit is equipped with advanced monitoring systems and supported by a multidisciplinary team

Sun Pharma’s ‘Heart ke Liye 8’ campaign clocks 24.1 million views online

This includes 14.3 million views on YouTube and 9.8 million views on Meta platforms to amplify preventive heart health message

UICC report flags air pollution as major multi-cancer risk

The long-term exposure to fine particulate matter (PM2.5) increases overall cancer risk by 11%

Stereotaxis to acquire Robocath in deal aimed at expanding surgical robotics platform

Takara Bio and Resistomap forge deal to speed up global fight against superbugs

The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence

Department of Biotechnology invites applications for DBT Research Associateship 2025–26

Postdoctoral fellowship aims to build skilled talent pool in biotechnology and life sciences

Revvity aims to accelerate breakthroughs in cancer research

Revvity is positioning its technologies as a connected engine for discovery